002589.SZ Stock Analysis
00
Uncovered
Realcan Pharmaceutical Group Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Realcan Pharmaceutical Group Co., Ltd.. engages in the provision of medical services. The company is headquartered in Yantai, Shandong and currently employs 8,369 full-time employees. The company went IPO on 2011-06-10. The firm operates its businesses through three segments. The Medical segment is engaged in the provision of Chinese medicine materials, Chinese medicine tablets, Chinese patent medicines, chemical drug materials, chemical preparations, antibiotics, biochemical pharmaceuticals, biological products, psychotropic substances, anesthetic medicines and peptide hormones. The Equipment is engaged in the provision of medical equipment. The Mobile Medical segment is engaged in the provision of medical and logistics services and mobile medical information services. The firm conducts its businesses mainly within domestic markets, with Shandong as its main market.